XOMAP Q2 2017 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$309M

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+2358.2% YoY

Gross Profit

$9M79.7% margin

Operating Income

$1M12.0% margin

Net Income

$285,0002.6% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+4088.5%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$24M

Total Liabilities

$53M

Stockholders' Equity

-$29M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$443,000	+2358.2%
Gross Profit	$9M	-$13M	+165.4%
Operating Income	$1M	-$18M	+107.3%
Net Income	$285,000	-$15M	+101.9%